[go: up one dir, main page]

GB202303582D0 - Novel compounds, compositions and therapeutic uses thereof - Google Patents

Novel compounds, compositions and therapeutic uses thereof

Info

Publication number
GB202303582D0
GB202303582D0 GBGB2303582.7A GB202303582A GB202303582D0 GB 202303582 D0 GB202303582 D0 GB 202303582D0 GB 202303582 A GB202303582 A GB 202303582A GB 202303582 D0 GB202303582 D0 GB 202303582D0
Authority
GB
United Kingdom
Prior art keywords
compositions
novel compounds
therapeutic uses
therapeutic
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2303582.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Breakpoint Therapeutics GmbH
Original Assignee
Breakpoint Therapeutics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Breakpoint Therapeutics GmbH filed Critical Breakpoint Therapeutics GmbH
Priority to GBGB2303582.7A priority Critical patent/GB202303582D0/en
Publication of GB202303582D0 publication Critical patent/GB202303582D0/en
Priority to US18/600,347 priority patent/US20240336628A1/en
Priority to CN202480030758.1A priority patent/CN121079086A/en
Priority to AU2024237801A priority patent/AU2024237801A1/en
Priority to US18/600,365 priority patent/US12162895B2/en
Priority to US18/600,352 priority patent/US12145945B2/en
Priority to PCT/IB2024/052261 priority patent/WO2024189493A1/en
Priority to KR1020257033304A priority patent/KR20250153866A/en
Priority to EP24713728.4A priority patent/EP4676480A1/en
Priority to IL323132A priority patent/IL323132A/en
Priority to MX2025010552A priority patent/MX2025010552A/en
Ceased legal-status Critical Current

Links

GBGB2303582.7A 2023-03-10 2023-03-10 Novel compounds, compositions and therapeutic uses thereof Ceased GB202303582D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB2303582.7A GB202303582D0 (en) 2023-03-10 2023-03-10 Novel compounds, compositions and therapeutic uses thereof
EP24713728.4A EP4676480A1 (en) 2023-03-10 2024-03-08 Inhibitors of dna polymerase theta
US18/600,365 US12162895B2 (en) 2023-03-10 2024-03-08 DNA polymerase theta inhibitor for treatment of cancer
CN202480030758.1A CN121079086A (en) 2023-03-10 2024-03-08 DNA polymerase-θ inhibitors
AU2024237801A AU2024237801A1 (en) 2023-03-10 2024-03-08 Inhibitors of dna polymerase theta
US18/600,347 US20240336628A1 (en) 2023-03-10 2024-03-08 Novel compounds, compositions, and therapeutic uses thereof
US18/600,352 US12145945B2 (en) 2023-03-10 2024-03-08 Compounds, compositions, and therapeutic uses thereof
PCT/IB2024/052261 WO2024189493A1 (en) 2023-03-10 2024-03-08 Inhibitors of dna polymerase theta
KR1020257033304A KR20250153866A (en) 2023-03-10 2024-03-08 DNA polymerase theta inhibitor
IL323132A IL323132A (en) 2023-03-10 2025-09-03 Inhibitors of dna polymerase theta
MX2025010552A MX2025010552A (en) 2023-03-10 2025-09-08 Inhibitors of dna polymerase theta

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2303582.7A GB202303582D0 (en) 2023-03-10 2023-03-10 Novel compounds, compositions and therapeutic uses thereof

Publications (1)

Publication Number Publication Date
GB202303582D0 true GB202303582D0 (en) 2023-04-26

Family

ID=86052630

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2303582.7A Ceased GB202303582D0 (en) 2023-03-10 2023-03-10 Novel compounds, compositions and therapeutic uses thereof

Country Status (1)

Country Link
GB (1) GB202303582D0 (en)

Similar Documents

Publication Publication Date Title
GB202102895D0 (en) Novel compounds, compositions and therapeutic uses thereof
GB201915831D0 (en) Compounds, compositions and therapeutic uses thereof
IL315948A (en) Compounds, compositions, and methods
GB202415076D0 (en) 5-pyridine-1h-indazole compound, pharmaceutical composition, and use
IL315222A (en) Therapeutic compounds, formulations, and use thereof
GB202213163D0 (en) Novel compounds, compositions and therapeutic uses thereof
GB201915829D0 (en) Compounds, compositions and therapeutic uses thereof
GB201915828D0 (en) Compounds, compositions and therapeutic uses thereof
GB202319864D0 (en) Novel compounds, compositions and therapeutic uses thereof
GB202317939D0 (en) Novel compounds, compositions and therapeutic uses thereof
GB202317938D0 (en) Novel compounds, compositions and therapeutic uses thereof
GB202317368D0 (en) Novel compounds, compositions and therapeutic uses thereof
GB202306374D0 (en) Novel compounds, compositions and therapeutic uses thereof
GB202306377D0 (en) Novel compounds, compositions and therapeutic uses thereof
GB202303582D0 (en) Novel compounds, compositions and therapeutic uses thereof
GB202300691D0 (en) Novel compounds, compositions and therapeutic uses thereof
GB202300689D0 (en) Novel compounds, compositions and therapeutic uses thereof
GB202300686D0 (en) Novel compounds, compositions and therapeutic uses thereof
GB202216305D0 (en) Novel compounds, compositions and therapeutic uses thereof
GB202216303D0 (en) Novel compounds, compositions and therapeutic uses thereof
GB202216299D0 (en) Novel compounds, compositions and therapeutic uses thereof
GB202213166D0 (en) Novel compounds, compositions and therapeutic uses thereof
GB202213164D0 (en) Novel compounds, compositions and therapeutic uses thereof
GB202213167D0 (en) Novel compounds, compositions and therapeutic uses thereof
IL320161A (en) Compounds, compositions and methods

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)